|
|
Volumn 9, Issue 2, 2005, Pages 161-169
|
|
Nursing implications of imatinib as molecularly targeted therapy for gastrointestinal stromal tumors.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IMATINIB;
PIPERAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
PYRIMIDINE DERIVATIVE;
AGED;
AMBULATORY CARE;
CASE REPORT;
DRUG ANTAGONISM;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG INTERACTION;
DRUG MONITORING;
FEMALE;
GASTROINTESTINAL STROMAL TUMOR;
HUMAN;
NURSE ATTITUDE;
NURSING;
ONCOLOGY NURSING;
ORAL DRUG ADMINISTRATION;
ORGANIZATION AND MANAGEMENT;
PATIENT EDUCATION;
PHYSIOLOGY;
PROGNOSIS;
REVIEW;
SAFETY;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
AGED;
AMBULATORY CARE;
ANTINEOPLASTIC AGENTS;
DRUG DELIVERY SYSTEMS;
DRUG DESIGN;
DRUG INTERACTIONS;
DRUG MONITORING;
FEMALE;
GASTROINTESTINAL STROMAL TUMORS;
HUMANS;
NURSE'S ROLE;
ONCOLOGIC NURSING;
PATIENT EDUCATION;
PIPERAZINES;
PROGNOSIS;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
RECEPTOR PROTEIN-TYROSINE KINASES;
SAFETY;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 18944395385
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/05.cjon.161-169 Document Type: Review |
|
Times cited : (9)
|
|
References (56)
|
